EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Mitochondrial Targets in Ischaemic Heart Disease and Heart Failure, and their Potential for a More Efficient Clinical Translation. A Scientific Statement of the ESC Working Group on Cellular Biology of the Heart and the ESC Working Group on Myocardial Function

Melanie Paillard, Mahmoud Abdellatif, Ioanna Andreadou, Christian Bär, Luc Bertrand, Bianca J J M Brundel, Gemma Chiva-Blanch, Sean M Davidson, Dana Dawson, Fabio Di Lisa, Paul Evans, Zoltan Giricz und 18 weitere

European Journal of Heart Failure · 01.09.2025 · 27 (9) · 1720-1736

DOI: 10.1002/ejhf.3674 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift European Journal of Heart Failure, online erschienen am 04.05.2025. Verfasst von Melanie Paillard und 29 weiteren Autor:innen. Beteiligte Einrichtung: Laboratoire CarMeN-IRIS Team, INSERM, INRA, Université Claude Bernard Lyon-1, Bron, France. Hauptthemen laut MEDLINE: Heart Failure, Mitochondria, Heart, Myocardial Ischemia. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 210 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acute myocardial infarction (MI) remains a major cause of death and disability worldwide. No adjuvant treatment has yet been fully validated in patients to limit the progression from the initial tissue damage due to acute MI, to the development of heart failure. However, mitochondria have long been demonstrated to be a key target for cardioprotective strategies to reduce cell death that leads to left ventricular dysfunction and ultimately heart failure. While pre-clinical studies have investigated several mitoprotective strategies targeting different mitochondrial functions, such as oxidative stress or permeability transition pore opening, none have shown successful clinical translation so far. In this European Society of Cardiology scientific statement, we present recent research advances in the understanding of the mitochondrial alterations occurring in MI and in the discovery of key components of mitochondrial structure and function in order to improve drug development. We discuss the reasons for the failure of clinical translation and the remaining obstacles that need to be addressed, including timing of drug administration, tissue bioavailability and efficient mitochondrial targeting, together with the mitochondrial impact derived from risk factors, comorbidities and comedications. Taken together, this scientific statement aims to provides a consensus opinion from clinicians and basic scientists to translate some of the most promising mitoprotective targets into the clinical setting to protect against MI and heart failure.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart FailureMitochondria, HeartMyocardial IschemiaHumansSocieties, MedicalOxidative StressTranslational Research, Biomedical

Stichwörter der Autor:innen

CardioprotectionHeart failureIschaemia–reperfusion injuryMitochondria‐targeted drug therapy

Autor:innen und Institutionen

  • Laboratoire CarMeN-IRIS Team, INSERM, INRA, Université Claude Bernard Lyon-1, Bron, France.
  • Division of Cardiology, Department of Internal Medicine, Medical University of Graz, BioTechMed Graz, Graz, Austria.
  • Laboratory of Pharmacology, School of Pharmacy, National and Kapodistrian University of Athens, Athens, Greece.
  • Institute of Molecular and Translational Therapeutic Strategies (IMTTS), Hannover Medical School, Germany-Fraunhofer Institute for Toxicology and Experimental Medicine (ITEM), Hannover, Germany.
  • UCLouvain, Institute for Experimental and Clinical Research, Pole of Cardiovascular Research; WELBIO Department, WEL Research Institute, Brussels, Belgium.
  • Physiology, Amsterdam UMC Location Vrije Universiteit, Cardiovascular Sciences, Heart Failure and Arrhythmias, Amsterdam, The Netherlands.

Zitieren

APA

Paillard, M., Abdellatif, M., Andreadou, I., Bär, C., Bertrand, L., Brundel, B. J. J. M., Chiva-Blanch, G., Davidson, S. M., Dawson, D., Di Lisa, F., Evans, P., Giricz, Z., Hausenloy, D. J., Kleinbongard, P., Lezoualc'h, F., Liehn, E., Maack, C., Maguy, A., Murphy, E., …, & Krieg, T. (2025). Mitochondrial Targets in Ischaemic Heart Disease and Heart Failure, and their Potential for a More Efficient Clinical Translation. A Scientific Statement of the ESC Working Group on Cellular Biology of the Heart and the ESC Working Group on Myocardial Function. European Journal of Heart Failure, 27(9), 1720-1736. https://doi.org/10.1002/ejhf.3674

Vancouver

Paillard M, Abdellatif M, Andreadou I, Bär C, Bertrand L, Brundel BJJM, et al. Mitochondrial Targets in Ischaemic Heart Disease and Heart Failure, and their Potential for a More Efficient Clinical Translation. A Scientific Statement of the ESC Working Group on Cellular Biology of the Heart and the ESC Working Group on Myocardial Function. European Journal of Heart Failure. 2025;27(9):1720-1736. doi:10.1002/ejhf.3674

BibTeX
@article{Paillard2025,
  author = {Paillard, Melanie and Abdellatif, Mahmoud and Andreadou, Ioanna and Bär, Christian and Bertrand, Luc and Brundel, Bianca J J M and Chiva-Blanch, Gemma and Davidson, Sean M and Dawson, Dana and Di Lisa, Fabio and Evans, Paul and Giricz, Zoltan and Hausenloy, Derek J and Kleinbongard, Petra and Lezoualc'h, Frank and Liehn, Elisa and Maack, Christoph and Maguy, Ange and Murphy, Elizabeth and Perrino, Cinzia and Pesce, Maurizio and Rainer, Peter P and Streckfuss-Bömeke, Katrin and Thielmann, Matthias and Tian, Rong and Tocchetti, Carlo G and Van Der Velden, Jolanda and Van Linthout, Sophie and Zacchigna, Serena and Krieg, Thomas},
  title = {Mitochondrial Targets in Ischaemic Heart Disease and Heart Failure, and their Potential for a More Efficient Clinical Translation. A Scientific Statement of the ESC Working Group on Cellular Biology of the Heart and the ESC Working Group on Myocardial Function},
  journal = {European Journal of Heart Failure},
  year = {2025},
  volume = {27},
  number = {9},
  pages = {1720--1736},
  doi = {10.1002/ejhf.3674}
}
Kostenlos starten →